Help
eIF4E (Ser209) Recombinant Antibody, APC Conjugated

Applications

  • WB
  • IF

Reactivity

  • Human
  • Mouse
  • Rat
Overview
Catalog # bsm-52152r-apc-100ul
Product Name eIF4E (Ser209) Recombinant Antibody, APC Conjugated
Applications
WB IF
Reactivity Human, Mouse, Rat
Specifications
Conjugation APC
Host Rabbit
Source KLH conjugated Synthesised phosphopeptide derived from human eIF4E around the phosphorylation site of Ser209
Modification Site S209
Clonality Recombinant
Clone # 2B1
Isotype IgG
Concentration Lot Dependent
Purification purified by Protein A.
Storage Buffer Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Target
Gene ID 1977
Swiss Prot P06730
Subcellular location Cytoplasm, Nucleus
Synonyms AUTS19; CBP; EIF4E1; EIF4EL1; EIF4F; eIF-4E; EG668879; Eif4e-ps; If4e; IF4E_HUMAN; EIF4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein; IF4E_MOUSE; IF4E_RAT; eukaryotic translation initiation factor 4E; eIF4E (phospho-S209); p-eIF4E; phospho-eIF4E; eIF4E (phospho-Ser209)
Background Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-FMR1 complex this subunit mediates the binding to the mRNA cap.
Application Dilution
WB 1:500-2000
IF 1:100-500